| Dr Jonathan Nussdorf, MD | |
|
1514 Jefferson Hwy, New Orleans, LA 70121-2429 | |
| (504) 842-4000 | |
| Not Available |
| Full Name | Dr Jonathan Nussdorf |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 33 Years |
| Location | 1514 Jefferson Hwy, New Orleans, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407801517 | NPI | - | NPPES |
| 1664332 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD.09319R (Louisiana) | Secondary |
| 207WX0009X | Ophthalmology - Glaucoma Specialist | MD.09319R (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Leonard J Chabert Medical Center | Houma, LA | Hospital |
| Abrom Kaplan Memorial Hospital | Kaplan, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
| South Louisiana Medical Associates | 8527968650 | 107 |
News Archive
Helsinn, the Swiss Group focused on building quality cancer care, and BIAL - Portela & Ca. S.A., one of the largest Iberian pharmaceutical companies, today announce that they have entered into an agreement for the exclusive distribution and licence rights to Anamorelin in Spain, Portugal, Angola and Mozambique.
With the prospect of health-care reform still looming, pharmaceutical and biotech companies face tremendous pressure to keep the costs of their products down.
It is becoming more generally known that Parkinson's disease not only influences a patient's motor functions. Patients often also suffer from depression, fear and incontinence, for example. However, the disease also undermines the language processing ability. University of Groningen researcher Katrien Colman has found clear indications of this in Dutch native speaker patients.
The University of Otago's Christchurch School of Medicine and Health Sciences' 30 year expertise in free radical research will be a vital component of a new collaborative Centre of Research Excellence (CoRE), recently backed by major Government funding.
› Verified 9 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Helsinn, the Swiss Group focused on building quality cancer care, and BIAL - Portela & Ca. S.A., one of the largest Iberian pharmaceutical companies, today announce that they have entered into an agreement for the exclusive distribution and licence rights to Anamorelin in Spain, Portugal, Angola and Mozambique.
With the prospect of health-care reform still looming, pharmaceutical and biotech companies face tremendous pressure to keep the costs of their products down.
It is becoming more generally known that Parkinson's disease not only influences a patient's motor functions. Patients often also suffer from depression, fear and incontinence, for example. However, the disease also undermines the language processing ability. University of Groningen researcher Katrien Colman has found clear indications of this in Dutch native speaker patients.
The University of Otago's Christchurch School of Medicine and Health Sciences' 30 year expertise in free radical research will be a vital component of a new collaborative Centre of Research Excellence (CoRE), recently backed by major Government funding.
› Verified 9 days ago
| Entity Name | South Louisiana Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942301379 PECOS PAC ID: 8527968650 Enrollment ID: O20040113000589 |
News Archive
Helsinn, the Swiss Group focused on building quality cancer care, and BIAL - Portela & Ca. S.A., one of the largest Iberian pharmaceutical companies, today announce that they have entered into an agreement for the exclusive distribution and licence rights to Anamorelin in Spain, Portugal, Angola and Mozambique.
With the prospect of health-care reform still looming, pharmaceutical and biotech companies face tremendous pressure to keep the costs of their products down.
It is becoming more generally known that Parkinson's disease not only influences a patient's motor functions. Patients often also suffer from depression, fear and incontinence, for example. However, the disease also undermines the language processing ability. University of Groningen researcher Katrien Colman has found clear indications of this in Dutch native speaker patients.
The University of Otago's Christchurch School of Medicine and Health Sciences' 30 year expertise in free radical research will be a vital component of a new collaborative Centre of Research Excellence (CoRE), recently backed by major Government funding.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Nussdorf, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Dr Jonathan Nussdorf, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 |
News Archive
Helsinn, the Swiss Group focused on building quality cancer care, and BIAL - Portela & Ca. S.A., one of the largest Iberian pharmaceutical companies, today announce that they have entered into an agreement for the exclusive distribution and licence rights to Anamorelin in Spain, Portugal, Angola and Mozambique.
With the prospect of health-care reform still looming, pharmaceutical and biotech companies face tremendous pressure to keep the costs of their products down.
It is becoming more generally known that Parkinson's disease not only influences a patient's motor functions. Patients often also suffer from depression, fear and incontinence, for example. However, the disease also undermines the language processing ability. University of Groningen researcher Katrien Colman has found clear indications of this in Dutch native speaker patients.
The University of Otago's Christchurch School of Medicine and Health Sciences' 30 year expertise in free radical research will be a vital component of a new collaborative Centre of Research Excellence (CoRE), recently backed by major Government funding.
› Verified 9 days ago
Dr. Michael Insler, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5649 Marcia Avenue, New Orleans, LA 70124 Phone: 504-400-7336 Fax: 504-412-1954 | |
Dr. Shalimar Small, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 533 Bolivar St, New Orleans, LA 70112 Phone: 504-268-2201 | |
Dr. Delmar Caldwell, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-2300 Fax: 504-988-8886 | |
Dr. Sharon H Gillen, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 266 Walnut St, New Orleans, LA 70118 Phone: 504-669-7499 | |
Dr. Jacob Daniel Grodsky, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3000 | |
Dr. Rebecca C Metzinger, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, Sl69, New Orleans, LA 70112 Phone: 504-988-5831 | |
Ms. Denise Elizabeth Capps, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-0543 |